Phosphinic peptide derivatives for use as MMP-12 inhibitors
US10179797B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2016 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | Nov 23, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5728
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), to cosmetic and pharmaceutical compositions containing them, and to their use in the prevention and/or treatment of ailments associated with MMP-12. Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.